0.9(top 50%)
impact factor
479(top 50%)
papers
6.0K(top 20%)
citations
37(top 20%)
h-index
0.9(top 50%)
impact factor
565
all documents
6.3K
doc citations
57(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular ProtectionCardiovascular & Hematological Disorders Drug Targets2007253
2Reactive Oxygen Species in Vascular WallCardiovascular & Hematological Disorders Drug Targets2006142
3Heparin Induced Thrombocytopenia: Pathogenetic, Clinical, Diagnostic and Therapeutic AspectsCardiovascular & Hematological Disorders Drug Targets2007127
4Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and InfectionCardiovascular & Hematological Disorders Drug Targets2008126
5Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart DiseasesCardiovascular & Hematological Disorders Drug Targets2007114
6Renal Endothelial Dysfunction in Acute Kidney Ischemia Reperfusion InjuryCardiovascular & Hematological Disorders Drug Targets2014112
7Renal Endothelial Dysfunction in Diabetic NephropathyCardiovascular & Hematological Disorders Drug Targets2014102
8Anti-Inflammatory Effects of Different Drugs/Agents with Antioxidant Property on Endothelial Expression of Adhesion MoleculesCardiovascular & Hematological Disorders Drug Targets200686
9A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-ProphylaxisCardiovascular & Hematological Disorders Drug Targets200978
10Na+/Ca2+ Exchange Inhibitors: A New Class of Calcium RegulatorsCardiovascular & Hematological Disorders Drug Targets200776
11Oxidative Stress and Transforming Growth Factor-.&#946;<sub>1</sub>-induced Cardiac FibrosisCardiovascular & Hematological Disorders Drug Targets201376
12Neutrophil Migration Under Normal and Sepsis ConditionsCardiovascular & Hematological Disorders Drug Targets201569
13Orthostatic Hypotension: Evaluation and TreatmentCardiovascular & Hematological Disorders Drug Targets200768
14Pathogenesis of Neointima Formation Following Vascular InjuryCardiovascular & Hematological Disorders Drug Targets201167
15Adiponectin and its Role in Cardiovascular DiseasesCardiovascular & Hematological Disorders Drug Targets200866
16Thrombotic Microangiopathies: Towards a Pathophysiology-Based ClassificationCardiovascular & Hematological Disorders Drug Targets200964
17Adipose Tissue: The Link Between Obesity and Cardiovascular DiseaseCardiovascular & Hematological Disorders Drug Targets200862
18Cyclooxygenase-2 Inhibitors: A Painful LessonCardiovascular & Hematological Disorders Drug Targets200659
19Glucose-6-Phosphate Dehydrogenase Deficiency: Disadvantages and Possible BenefitsCardiovascular & Hematological Disorders Drug Targets201358
20Human Apolipoprotein C-III – A New Intrahepatic Protein Factor Promoting Assembly and Secretion of Very Low Density LipoproteinsCardiovascular & Hematological Disorders Drug Targets201257
21Immunomodulatory and Anti-inflammatory Effects of ThymoquinoneCardiovascular & Hematological Disorders Drug Targets201855
22Complications of Infective EndocarditisCardiovascular & Hematological Disorders Drug Targets200954
23Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer PatientsCardiovascular & Hematological Disorders Drug Targets201052
24Platelets in Thrombosis and Hemostasis: Old Topic with New MechanismsCardiovascular & Hematological Disorders Drug Targets201252
25Glucagon-Like Peptide-1 as a Key Regulator of Lipid and Lipoprotein Metabolism in Fasting and Postprandial StatesCardiovascular & Hematological Disorders Drug Targets201445
26Endothelial Progenitors in Vascular Repair and Angiogenesis: How Many are Needed and What to do?Cardiovascular & Hematological Disorders Drug Targets200844
27Risk Factors and Mediators of the Vascular Dysfunction Associated with Hypertension in PregnancyCardiovascular & Hematological Disorders Drug Targets201044
28Medial Vascular Calcification in Diabetes Mellitus and Chronic Kidney Disease: The Role of InflammationCardiovascular & Hematological Disorders Drug Targets200743
29Targeting Adhesion Molecules in Cardiovascular DisordersCardiovascular & Hematological Disorders Drug Targets200843
30Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple MyelomaCardiovascular & Hematological Disorders Drug Targets201342
31The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2Cardiovascular & Hematological Disorders Drug Targets201842
32Mitochondrial Dysfunction, Oxidative Stress and Diabetic Cardiovascular DisordersCardiovascular & Hematological Disorders Drug Targets201242
33Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells ProliferationCardiovascular & Hematological Disorders Drug Targets200941
34Targeting Leukostasis for the Treatment of Early Diabetic RetinopathyCardiovascular & Hematological Disorders Drug Targets200941
35Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in SepsisCardiovascular & Hematological Disorders Drug Targets201541
36Cardiolipin Metabolism and the Role it Plays in Heart Failure and Mitochondrial Supercomplex FormationCardiovascular & Hematological Disorders Drug Targets201441
37Neuroinflammation in Sepsis: Sepsis Associated DeliriumCardiovascular & Hematological Disorders Drug Targets201540
38Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major OrgansCardiovascular & Hematological Disorders Drug Targets201540
39Diabetes, Hyperglycemia and Accelerated Atherosclerosis: Evidence Supporting a Role for Endoplasmic Reticulum (ER) Stress SignalingCardiovascular & Hematological Disorders Drug Targets201039
40Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysisCardiovascular & Hematological Disorders Drug Targets201338
41Citrus Flavonoids and the Prevention of AtherosclerosisCardiovascular & Hematological Disorders Drug Targets201237
42Mast Cells and Inflammatory Heart Disease: Potential Drug TargetsCardiovascular & Hematological Disorders Drug Targets200836
43Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative StressCardiovascular & Hematological Disorders Drug Targets201036
44Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?Cardiovascular & Hematological Disorders Drug Targets200635
45Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug DevelopmentCardiovascular & Hematological Disorders Drug Targets200835
46Cardiovascular Disease: What's All the AGE/RAGE About?Cardiovascular & Hematological Disorders Drug Targets201034
47Nanoparticle Based Treatment for Cardiovascular DiseasesCardiovascular & Hematological Disorders Drug Targets201934
48Atherosclerotic Coronary Heart Disease Epidemiology, Classification and ManagementCardiovascular & Hematological Disorders Drug Targets201033
49Vascular C-Reactive Protein in the Pathogenesis of Coronary Artery Disease:Role of Vascular Inflammation and Oxidative StressCardiovascular & Hematological Disorders Drug Targets200633
50Novel Insights Into Lp(a) Physiology and Pathogenicity: More Questions Than Answers?Cardiovascular & Hematological Disorders Drug Targets200633